Fabrizio Conti


Titolo Pubblicato in Anno
Should we vaccinate during an active rheumatic disease? AUTOIMMUNITY REVIEWS 2023
Early and late response and glucocorticoid-sparing effect of belimumab in patients with systemic lupus erythematosus with joint and skin manifestations. results from the belimumab in real life setting study-joint and skin (BeRLiSS-JS) JOURNAL OF PERSONALIZED MEDICINE 2023
Systematic literature review of real-world evidence on baricitinib for the treatment of rheumatoid arthritis RHEUMATOLOGY AND THERAPY 2023
Fragility fractures in lupus patients:. associated factors and comparison of four fracture risk assessment tools LUPUS 2023
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib. SCIENTIFIC REPORTS 2023
Rheumatoid arthritis from easy to complex disease. from the "2022 GISEA international symposium" JOURNAL OF CLINICAL MEDICINE 2023
Organ damage in systemic lupus erythematosus patients. a multifactorial phenomenon AUTOIMMUNITY REVIEWS 2023
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Janus kinase inhibitors: between prescription authorization and reimbursability REUMATISMO 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia. a registry-based study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Exercise-induced modulation of Interferon-signature. a therapeutic route toward management of systemic lupus erythematosus AUTOIMMUNITY REVIEWS 2023
Telemedicine for rheumatological consultation. the new semeiotics for rheumatic examination CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis. results from the observational GCAGE study on a large cohort of 1004 patients ANNALS OF THE RHEUMATIC DISEASES 2023
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro LUPUS 2023
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the italian PsABio cohort CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
From bench to bedside in rheumatoid arthritis from the "2022 GISEA international symposium" JOURNAL OF CLINICAL MEDICINE 2023
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2023
Belimumab decreases autophagy and citrullination in peripheral blood mononuclear cells from patients with systemic lupus erythematosus CELLS 2022
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine ARTHRITIS RESEARCH & THERAPY 2022
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome. a new tool for diagnosis of "seronegative" patients RHEUMATOLOGY 2022

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma